Cargando…

Effects of Chemoendocrine Therapy on the Coagulation‐Fibrinolytic Systems in Patients with Advanced Breast Cancer

In order to predict a hypercoagulable state in patients with advanced breast cancer receiving medical treatment, the effects of Chemoendocrine therapy on the coagulation‐flbrinolytic systems were investigated prospectively. The patients were randomly divided into two groups. The ACT group had 38 pat...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1993
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919309/ https://www.ncbi.nlm.nih.gov/pubmed/8514613 http://dx.doi.org/10.1111/j.1349-7006.1993.tb00158.x

Ejemplares similares

Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR
por: Ueno, Takayuki, et al.
Publicado: (2019)

Changes in the Coagulation and Fibrinolytic System of Patients with Subarachnoid Hemorrhage
por: JI, Yong, et al.
Publicado: (2014)

Association of Survival With Chemoendocrine Therapy in Women With Small, Hormone Receptor–Positive, ERBB2-Positive, Node-Negative Breast Cancer
por: Ma, Sung Jun, et al.
Publicado: (2020)

Fibrinolytic and coagulative activities of Yersinia pestis
por: Korhonen, Timo K., et al.
Publicado: (2013)

Disequilibrium of Blood Coagulation and Fibrinolytic System in Patients With Coronary Artery Ectasia
por: Wu, Wei, et al.
Publicado: (2016)

The Inflammatory Actions of Coagulant and Fibrinolytic Proteases in Disease
por: Schuliga, Michael
Publicado: (2015)

Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype
por: Hayakawa, Mineji
Publicado: (2017)

The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19
por: Onishi, Tomoko, et al.
Publicado: (2022)

Effects of whole-body vibration training on fibrinolytic and coagulative factors in healthy young men
por: Ghazalian, Farshad, et al.
Publicado: (2014)

Neurointensive Care of Traumatic Brain Injury Patients Based on Coagulation and Fibrinolytic Parameter Monitoring
por: NAKAE, Ryuta, et al.
Publicado: (2022)

Age-Related Differences in the Time Course of Coagulation and Fibrinolytic Parameters in Patients with Traumatic Brain Injury
por: Nakae, Ryuta, et al.
Publicado: (2020)

Platelet, Fibrinolytic and Other Coagulation Abnormalities in Newly-Diagnosed Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Vrigkou, Eleni, et al.
Publicado: (2022)

Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement
por: Sayyadi, Mohammad, et al.
Publicado: (2023)

Disseminated intravascular coagulation with the fibrinolytic phenotype predicts the outcome of patients with out-of-hospital cardiac arrest
por: Wada, Takeshi, et al.
Publicado: (2016)

Control of fibrinolytic drug injection via real-time ultrasonic monitoring of blood coagulation
por: Ivlev, Dmitry A., et al.
Publicado: (2019)

Fibrinolytic Therapy in Acute Stroke
por: Millán, Mònica, et al.
Publicado: (2010)

Antithrombin effect on coagulation and fibrinolytic profiles after living donor liver transplantation: a pilot study
por: KANEKO, J, et al.
Publicado: (2009)

Changes in Biomarkers of Coagulation, Fibrinolytic, and Endothelial Functions for Evaluating the Predisposition to Venous Thromboembolism in Patients With Hereditary Thrombophilia
por: Li, Lei, et al.
Publicado: (2020)

Automated measurement of coagulation and fibrinolytic activation markers: Outcomes in coronavirus disease 2019 (COVID‐19) patients
por: Gardiner, Chris, et al.
Publicado: (2022)

Therapeutics targeting the fibrinolytic system
por: Lin, Haili, et al.
Publicado: (2020)

A case of hemothorax secondary to intrapleural fibrinolytic therapy: Considerations for use of fibrinolytics in high-risk patients
por: Narula, Naureen, et al.
Publicado: (2021)

The Fibrinolytic System: Mysteries and Opportunities
por: Medcalf, Robert L., et al.
Publicado: (2021)

Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications
por: Mahmood, Niaz, et al.
Publicado: (2021)

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Changes in fibrinolytic activity and coagulation factors after epicardial left atrial appendage closure in patients with atrial fibrillation
por: Litwinowicz, Radoslaw, et al.
Publicado: (2022)

Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation
por: Huang, Ying, et al.
Publicado: (2014)

The Role of Fibrinolytic System in Health and Disease
por: Kwaan, Hau C.
Publicado: (2022)

Efficacy of standardizing fibrinolytic therapy for parapneumonic effusion
por: James, Charles A., et al.
Publicado: (2022)

Impact of initial coagulation and fibrinolytic markers on mortality in patients with severe blunt trauma: a multicentre retrospective observational study
por: Ishii, Kenta, et al.
Publicado: (2019)

Evaluation of fibrinolytic medical therapy for patients with acute myocardial infarction
por: Maleki, Ali, et al.
Publicado: (2012)

Systemic Fibrinolytic Therapy in the Presence of Absolute Contraindication; a Case Series
por: Pishgahi, Mahdi, et al.
Publicado: (2018)

Polymorphic Variation of Genes in the Fibrinolytic System and the Risk of Ovarian Cancer
por: Bentov, Yaakov, et al.
Publicado: (2009)

Fibrinolytic therapy for parapneumonic empyema during pregnancy
por: Ulutas, Hakki, et al.
Publicado: (2011)

VATS and Intrapleural Fibrinolytic Therapy for Parapneumonic Empyema
por: Ohara, Gen, et al.
Publicado: (2018)

Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy
por: Altaf, Farwa, et al.
Publicado: (2021)

Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019
por: Zhong, Yajuan, et al.
Publicado: (2021)

Association of Fibrinolytic Potential and Risk of Mortality in Cancer Patients
por: Gois, Gabriele Silva Souza, et al.
Publicado: (2023)

Comprehensive coagulation and fibrinolytic potential in the acute phase of pediatric patients with idiopathic nephrotic syndrome evaluated by whole blood-based rotational thromboelastometry
por: Ishikawa, Tomoaki, et al.
Publicado: (2022)

Effect of Rivaroxaban on Fibrinolytic Therapy in Massive Pulmonary Embolism: Two Cases
por: Kim, Hye-Jin, et al.
Publicado: (2014)

Coagulation/fibrinolysis and circulating tumor cells in patients with advanced breast cancer
por: Dirix, Luc Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7jnrkboou6plj1evi1716ftlmv